VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 70 filers reported holding VOYAGER THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $278 | -99.6% | 24,321 | +125.5% | 0.00% | +100.0% |
Q2 2022 | $64,000 | -46.2% | 10,787 | -30.8% | 0.00% | -50.0% |
Q1 2022 | $119,000 | -18.5% | 15,590 | -55.9% | 0.00% | 0.0% |
Q2 2021 | $146,000 | +67.8% | 35,328 | +189.5% | 0.00% | +100.0% |
Q4 2020 | $87,000 | -58.4% | 12,205 | -37.6% | 0.00% | -75.0% |
Q3 2020 | $209,000 | -60.3% | 19,556 | -53.1% | 0.00% | -71.4% |
Q2 2020 | $526,000 | +239.4% | 41,716 | +275.8% | 0.01% | +366.7% |
Q4 2019 | $155,000 | – | 11,100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP III, LLC | 6,391,176 | $120,921,000 | 54.00% |
Trustees of Princeton University | 203,632 | $3,853,000 | 5.43% |
GREAT POINT PARTNERS LLC | 1,400,000 | $26,488,000 | 4.13% |
Casdin Capital, LLC | 1,135,000 | $21,474,000 | 2.61% |
ARMISTICE CAPITAL, LLC | 1,724,000 | $32,618,000 | 1.96% |
BB BIOTECH AG | 2,822,641 | $53,404,000 | 1.41% |
HARBOURVEST PARTNERS LLC | 72,726 | $1,376,000 | 1.24% |
Aevitas Wealth Management, Inc. | 62,323 | $1,179,000 | 1.07% |
HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,001,870 | $18,955,000 | 0.88% |
Patriot Financial Group Insurance Agency, LLC | 60,586 | $1,146,000 | 0.68% |